Cite
HARVARD Citation
Cefalo, M. et al. (2021). Effectiveness of emicizumab in preventing life‐threatening bleeding complications in type 3 von Willebrand disease with inhibitors: A paediatric report. Haemophilia. 27 (4), pp. e495-e497. [Online].